scispace - formally typeset
D

Dechun Geng

Researcher at Soochow University (Suzhou)

Publications -  139
Citations -  2448

Dechun Geng is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 20, co-authored 91 publications receiving 1261 citations.

Papers
More filters
Journal ArticleDOI

A Comparison of the Proximal Femoral Nail Antirotation Device and Dynamic Hip Screw in the Treatment of Unstable Pertrochanteric Fracture

TL;DR: The PFNA allowed earlier mobilization and faster recovery than the DHS, and time to mobilization with a frame was significantly shorter in the PFNA, and post-operative complications were more common in the DHS group.
Journal ArticleDOI

Icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model

TL;DR: It is suggested that icariin represents a potential treatment for titanium particle-induced osteolysis and could be developed as a new therapeutic candidate for the prevention and treatment of aseptic loosening.
Journal ArticleDOI

Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.

TL;DR: It is found that the exogenous administration of melatonin significantly inhibited wear debris-induced bone resorption and the expression of inflammatory cytokines in vivo and melatonin inhibits receptor activator of nuclear factor kappa-B ligand induced osteoclast formation and osteoclastic bone Resorption in vitro.
Journal ArticleDOI

Biomimetic osteogenic peptide with mussel adhesion and osteoimmunomodulatory functions to ameliorate interfacial osseointegration under chronic inflammation.

TL;DR: It is indicated that biomimetic peptides with osteoimmunomodulatory bioactivity can be incorporated into Ti-based prostheses to facilitate bone regeneration in patients with chronic inflammatory diseases.
Journal ArticleDOI

Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.

TL;DR: Dopamine therapy could be developed into an effective and safe method for osteolysis-related disease caused by chronic inflammation and excessive osteoclast formation.